Digital pathology (DP) is transitioning from an adjunct technology to an enterprise diagnostic platform in the United States.

Charles River Laboratories International, Inc. (NYSE: CRL) today announced continued momentum in its digital pathology platform, delivering an end-to-end, AI-enabled workflow that significantly ...

MARION, Ill. (WSIL) — CorePath Laboratories has launched an integrated digital pathology network in collaboration with Deaconess Illinois Medical Center, marking a significant step forward in ...

The UAB Department of Pathology launched its digital pathology initiative in November 2024. Today, the effort is only gaining momentum. The program’s implementation is scheduled to be completed by ...

Kameda Medical Center, a private medical group in Japan, has started implementing a digital pathology system as part of its transition to a new enterprise pathology platform. According to a press ...

In this interview, industry expert Dr. Raj Singh discusses the PathoVerse, a pioneering global digital ecosystem designed to transform pathology through connectivity, AI integration, and collaborative ...

In the most traditional definition of return-on-investment, Sam Terese, former CEO and president of Alverno Laboratories, would say that his company isn’t experiencing a strict apples-to-apples ...

This Special Article provides a comprehensive review and expert commentary on the prospective clinical implementation of artificial intelligence (AI) in the detection of prostate cancer from digital ...

Dan Roark, CEO of Gestalt, at the company’s Spokane HQ in February 2024. (GeekWire File Photo / Todd Bishop) Gestalt Diagnotistics, a Spokane, Wash.-based healthcare startup, has raised $7.5 million ...

Antibody-drug conjugates (ADCs) are a novel class of cancer therapeutics comprised of a linker-payload conjugated to a selective monoclonal antibody targeting a tumor-associated antigen (TAA) to ...